|
注册号: Registration number: |
ChiCTR2500105203 |
|
最近更新日期: Date of Last Refreshed on: |
2025-06-30 17:46:54 |
|
注册时间: Date of Registration: |
2025-06-30 00:00:00 |
|
注册号状态: |
补注册 |
|
Registration Status: |
Retrospective registration |
|
注册题目: |
新型纳米氧化锆用于全牙列固定修复疗效观察 |
|
Public title: |
Novel nano-zirconia was used for the observation of the efficacy of total dentition fixation restoration |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
新型纳米氧化锆用于全牙列固定修复疗效观察 |
|
Scientific title: |
Novel nano-zirconia was used for the observation of the efficacy of total dentition fixation restoration |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
李颖 |
研究负责人: |
李颖 |
|
Applicant: |
Li Ying |
Study leader: |
Li Ying |
|
申请注册联系人电话: Applicant telephone: |
+86 153 1604 9292 |
研究负责人电话:
Study leader's |
+86 153 1604 9292 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
151011266@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
151011266@qq.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
上海市虹口区四川北路街道国贸花园3号楼1704室 |
研究负责人通讯地址: |
上海市虹口区四川北路街道国贸花园3号楼1704室 |
|
Applicant address: |
Room 1704, Building 3, Guomao Garden, Sichuan North Road Street, Hongkou District, Shanghai |
Study leader's address: |
Room 1704, Building 3, Guomao Garden, Sichuan North Road Street, Hongkou District, Shanghai |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
上海市虹口区江湾医院 |
||
|
Applicant's institution: |
Jiangwan Hospital, Hongkou District, Shanghai |
||
|
研究负责人所在单位: |
上海市虹口区江湾医院 |
||
|
Affiliation of the Leader: |
Jiangwan Hospital, Hongkou District, Shanghai |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2023第(011)号 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
上海市虹口区江湾医院伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee of Jiangwan Hospital, Hongkou District, Shanghai |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2023-05-10 00:00:00 | ||
|
伦理委员会联系人: |
罗振东 |
||
|
Contact Name of the ethic committee: |
Luo Zhen-dong |
||
|
伦理委员会联系地址: |
上海市虹口区四川北路1878号 |
||
|
Contact Address of the ethic committee: |
1878 North Sichuan Road, Hongkou District, Shanghai |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 180 1730 0780 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
上海市江湾医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Shanghai Jiangwan Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
上海市虹口区四川北路1878号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
1878 North Sichuan Road, Hongkou District, Shanghai |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
上海市虹口区健康卫生委员会及上海市虹口区江湾医院 |
||||||||||||||||||||||
|
Source(s) of funding: |
Shanghai Hongkou District Health Commission and Shanghai Hongkou District Jiangwan Hospital |
||||||||||||||||||||||
|
研究疾病: |
口腔牙列缺损 |
||||||||||||||||||||||
|
Target disease: |
Oral dentition defects |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
单臂 |
||||||||||||||||||||||
|
Study design: |
Single arm |
||||||||||||||||||||||
|
研究目的: |
研究制定全牙列固定修复临床范式,并开展科室建设,进行固定长桥冠修复临床推广,推动全牙列固定修复发展。 |
||||||||||||||||||||||
|
Objectives of Study: |
To study and formulate the clinical paradigm of full dentition fixed restoration, carry out the construction of departments, and carry out the clinical promotion of fixed long-bridge crown restoration, so as to promote the development of full dentition fixed restoration. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
(1)有严重系统性疾病; (2)有长期吸烟史; (3)槽骨吸收大于根长1/2; |
||||||||||||||||||||||
|
Exclusion criteria: |
(1)Severe systemic diseases; (2)long-term smoking history; (3)Alveolar bone resorption greater than 1/2 root length; |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2023-10-11 00:00:00至 To 2025-03-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2023-10-11 00:00:00 至 To 2023-12-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
结束 /Completed |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
|
|
Blinding: |
|
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
公开原始数据日期为2025.9.30,采用ResMan平台方式公开,网址为:http://www.medresman.org.cn/login.aspx |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
The original data was published on September 30, 2025, using the ResMan platform at http://www.medresman.org.cn/login.aspx |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
数据由专业人员填写在患者手册里,双人双次录入数据,后续数据导出,两次不一致的再跟原始数据手册对比,应用SPSS 25.0统计学软件进行统计分析和处理,计数数据以率(%)表示,采用构成比和Wilcoxon秩和检验对不同随访时间点的临床指标进行比较分析。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
The data were filled in by professionals in the patient manual, and two people entered the data twice, followed by data export, and two inconsistent data were compared with the original data manual. SPSS 25.0 statistical software was used for statistical analysis and processing, and the count data were expressed as rate (%). Constituent ratio and Wilcoxon rank sum test were used to compare and analyze the clinical indicators at different follow-up time points. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |